Safeguard Scientifics Inc.
SFES OTC
SEC CIK 86115
Follow Safeguard Scientifics
Weekly email: filings, results
Net income
−$9.8M
+31.1% vs prior year
EPS, diluted
−$0.61
+29.9% vs prior year
Operating cash flow
−$3.3M
−1.5% vs prior year
Operating income
−$5.7M
−19% vs prior year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY23 | −$9.8M |
| FY22 | −$14.3M |
| FY21 | $27M |
| FY20 | −$37.6M |
| FY19 | $54.6M |
| FY18 | −$15.6M |
| FY17 | −$88.6M |
| FY16 | −$22.3M |
| FY15 | −$59.5M |
| FY14 | −$5.1M |
| FY13 | −$35.5M |
| FY12 | −$39.4M |
| FY11 | $110.6M |
| FY10 | $26.6M |
| FY09 | $67.6M |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | −$20.8M |
| FY16 | −$19.1M |
| FY15 | −$19.6M |
| FY14 | −$20.2M |
| FY13 | −$21.3M |
| FY12 | −$16.6M |
| FY11 | −$17.8M |
| FY10 | −$16.1M |
| FY09 | −$21.3M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY23 | $5.8M | $75K |
| FY22 | $0 | $2.9M |
| FY21 | - | $40.7M |
| FY20 | $0 | $0 |
| FY19 | $20.7M | - |
| FY18 | $0 | - |
| FY17 | - | $0 |
| FY16 | - | $5.4M |
| FY15 | - | $5M |
| FY14 | - | $25M |
| FY13 | - | $122K |
| FY12 | - | $0 |
| FY11 | - | $0 |
| FY10 | - | - |
| FY09 | - | $44K |